Nobel Prize Honors Groundbreaking Body's Defenses Discoveries
This year's prestigious award in Physiology or Medicine was granted for transformative discoveries that illuminate how the immune system targets dangerous infections while protecting the healthy tissues.
Three esteemed scientists—Japan's Shimon Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—received this accolade.
Their research uncovered unique "sentinels" within the defense system that remove malfunctioning defense cells capable of harming the body.
These discoveries are now enabling new therapies for immune disorders and malignancies.
The winners will share a monetary award valued at 11m SEK.
Decisive Discoveries
"Their work has been essential for comprehending how the body's defenses operates and why we do not all develop severe self-attack conditions," stated the head of the Nobel Committee.
The team's studies explain a fundamental mystery: In what way does the defense system defend us from countless infections while leaving our own tissues intact?
Our immune system employs white blood cells that scan for signs of infection, including viruses and germs it has never encountered.
Such defenders utilize detectors—known as recognition units—that are produced by chance in countless variations.
That provides the defense network the ability to fight a wide array of threats, but the randomness of the process inevitably produces white blood cells that can target the host.
Protectors of the Immune System
Scientists earlier knew that some of these harmful white blood cells were destroyed in the thymus—where white blood cells mature.
This year's award recognizes the discovery of regulatory T-cells—known as the body's "peacekeepers"—which travel through the system to neutralize any immune cells that assault the healthy cells.
We know that this mechanism fails in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.
A prize committee stated, "These discoveries have established a novel area of investigation and spurred the creation of new therapies, for instance for cancer and immune disorders."
In malignancies, T-regs block the body from fighting the growth, so research are focused on lowering their quantity.
For self-attack disorders, trials are exploring boosting T-reg cells so the body is no longer being harmed. A comparable method could also be effective in reducing the risks of transplanted organ failure.
Innovative Experiments
Professor Shimon Sakaguchi, of Osaka University, conducted tests on rodents that had their thymus extracted, leading to self-attack conditions.
He demonstrated that injecting defense cells from other mice could prevent the disease—suggesting there was a mechanism for preventing immune cells from attacking the body.
Dr. Brunkow, from the Institute for Systems Biology in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an genetic immune disorder in mice and people that resulted in the discovery of a gene critical for how T-regs operate.
"Their pioneering research has uncovered how the body's defenses is controlled by T-reg cells, stopping it from mistakenly attacking the body's own tissues," said a prominent biological science expert.
"This research is a striking illustration of how fundamental biological research can have far-reaching consequences for human health."
